RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 3 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2012. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,000 | 0.0% | 660 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 660 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 660 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | -60.0% | 660 | -50.4% | 0.00% | – |
| Q3 2016 | $5,000 | +25.0% | 1,330 | -33.5% | 0.00% | – |
| Q2 2016 | $4,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2016 | $4,000 | -60.0% | 2,000 | -40.7% | 0.00% | – |
| Q4 2015 | $10,000 | +150.0% | 3,370 | +203.3% | 0.00% | – |
| Q2 2015 | $4,000 | -91.3% | 1,111 | -84.1% | 0.00% | -100.0% |
| Q1 2013 | $46,000 | -29.2% | 7,000 | -30.0% | 0.00% | 0.0% |
| Q4 2012 | $65,000 | -36.3% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q3 2012 | $102,000 | +9.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2012 | $93,000 | +14.8% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2012 | $81,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |